Drug intelligence / Profile preview

KD-045

Development stage: Preclinical
Lead developer: Nanjing KAEDI Biotech
Modality: CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies, Gene Silencing → Gene Therapies, Gene Editing → Gene Therapies, Gene Addition/Replacement → Gene Therapies
Administration: Parenteral

Overview

KD-045 is a CD47-CAR-NK cell therapy, which is a type of gene therapy, under development for the treatment of cancer. It is designed to be administered parenterally. This drug candidate was part of Kadmon Holdings' preclinical pipeline, with the company actively advancing its development.

Other names: KD-045-Nanjing KAEDI Biotech-CD47-CAR-NK cell therapy-Gene therapy-Parenteral-CancerKD045-Nanjing KAEDI Biotech-CD47-CAR-NK cell therapy-Gene therapy-Parenteral-CancerKD 045-Nanjing KAEDI Biotech-CD47-CAR-NK cell therapy-Gene therapy-Parenteral-Cancer

Targets

CD47 (Cluster of Differentiation 47)

Beyond the preview

Go deeper on KD-045.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KD-045.

Explore the full profile